Our Work / PACS
PACS examines how decisions about supply, inventory, shortages and preparedness interact across the healthcare value chain.
How can Europe strengthen medicines resilience while balancing patient access, effectiveness, cost, efficiency, equity and environmental consequences?
Shortages do not belong to one organisation. A disruption can appear as a forecasting problem to a manufacturer, an inventory problem to a distributor, an access problem to a pharmacist and a system problem to a regulator. PACS examines the chain as a whole.
Resilience is not simply about holding more stock. It is about understanding what to hold, where, why and for how long—and how each option affects patient access, operations, cost and the wider healthcare value chain.
Move from isolated responses towards smarter, more coordinated approaches that strengthen resilience and protect patient access.
Fifteen working definitions designed to support clearer discussion across manufacturers, distributors, healthcare providers, policymakers, regulators and patient organisations.
A structured examination of reserve and contingency models and the choices that determine how a reserve operates.
